David Hallas Acquires 22,346 Shares of ECO Animal Health Group (LON:EAH) Stock

ECO Animal Health Group plc (LON:EAH) insider David Hallas acquired 22,346 shares of ECO Animal Health Group stock in a transaction that occurred on Thursday, July 16th. The stock was bought at an average price of GBX 89 per share, with a total value of £19,887.94.

ECO Animal Health Group Price Performance

ECO Animal Health Group stock traded down GBX 1.25 during mid-day trading on Thursday, reaching GBX 87.25. The company had a trading volume of 527,851 shares, compared to its average volume of 81,107. The stock’s 50-day simple moving average is GBX 92.73 and its 200-day simple moving average is GBX 98.64. ECO Animal Health Group plc has a 1 year low of GBX 72 and a 1 year high of GBX 116.90. The company has a debt-to-equity ratio of 5.97, a current ratio of 3.73 and a quick ratio of 2.14. The company has a market capitalization of £58.53 million, a P/E ratio of 19.87 and a beta of 0.00.

ECO Animal Health Group (LON:EAH) last announced its quarterly earnings results on Wednesday, July 15th. The company reported GBX 3.26 EPS for the quarter. ECO Animal Health Group had a return on equity of 3.55% and a net margin of 3.52%.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.